Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Cell death mechanisms and potentially cytotoxic natural immune cells in human pregnancies complicated by preeclampsia.

Barakonyi A, Miko E, Szereday L, Polgar PD, Nemeth T, Szekeres-Bartho J, Engels GL.

Reprod Sci. 2014 Feb;21(2):155-66. doi: 10.1177/1933719113497288. Epub 2013 Jul 24. Review.

PMID:
23885100
2.

Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.

Kim HR, Park HJ, Park JH, Kim SJ, Kim K, Kim J.

Cancer Immunol Immunother. 2004 May;53(5):461-70. Epub 2003 Nov 28.

PMID:
14648068
3.

Phenotype of NK cells and cytotoxic/apoptotic mediators expression in ectopic pregnancy.

Laskarin G, Redzovic A, Vukelic P, Veljkovic D, Gulic T, Haller H, Rukavina D.

Am J Reprod Immunol. 2010 Nov;64(5):347-58. doi: 10.1111/j.1600-0897.2010.00844.x.

PMID:
20408833
4.

Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death.

Kim HR, Kim K, Lee KH, Kim SJ, Kim J.

Clin Exp Immunol. 2008 May;152(2):336-44. doi: 10.1111/j.1365-2249.2008.03622.x. Epub 2008 Mar 10.

5.

Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.

Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL.

J Immunol. 1999 Nov 15;163(10):5358-66.

6.

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells.

Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B.

J Exp Med. 1998 Dec 21;188(12):2375-80.

7.

Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.

Melki MT, Saïdi H, Dufour A, Olivo-Marin JC, Gougeon ML.

PLoS Pathog. 2010 Apr 15;6(4):e1000862. doi: 10.1371/journal.ppat.1000862.

8.

Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.

Zhang F, Chu X, Wang L, Zhu Y, Li L, Ma D, Peng J, Hou M.

Eur J Haematol. 2006 May;76(5):427-31. Epub 2006 Feb 15.

PMID:
16480433
9.

Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.

Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.

J Immunol. 1999 Aug 15;163(4):1906-13.

10.

Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.

Liu AN, Mohammed AZ, Rice WR, Fiedeldey DT, Liebermann JS, Whitsett JA, Braciale TJ, Enelow RI.

Am J Respir Cell Mol Biol. 1999 May;20(5):849-58.

PMID:
10226053
11.

Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.

Melgar S, Bas A, Hammarström S, Hammarström ML.

Immunology. 2002 Aug;106(4):476-85.

12.

The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.

Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B.

Cancer Immunol Immunother. 1997 Jul;44(5):282-90.

PMID:
9247563
13.

Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.

Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-Pickett R, Wiltrout RH.

J Immunol. 1998 Oct 15;161(8):3957-65.

14.

Human umbilical cord blood NK T cells kill tumors by multiple cytotoxic mechanisms.

Gansuvd B, Hagihara M, Yu Y, Inoue H, Ueda Y, Tsuchiya T, Masui A, Ando K, Nakamura Y, Munkhtuvshin N, Kato S, Thomas JM, Hotta T.

Hum Immunol. 2002 Mar;63(3):164-75.

PMID:
11872234
15.

Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells.

Screpanti V, Wallin RP, Grandien A, Ljunggren HG.

Mol Immunol. 2005 Feb;42(4):495-9. Review.

PMID:
15607805
17.

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

Lee SH, Bar-Haim E, Machlenkin A, Goldberger O, Volovitz I, Vadai E, Tzehoval E, Eisenbach L.

Cancer Gene Ther. 2004 Mar;11(3):237-48.

PMID:
14739939
18.

[Current advances and expectations in tumor immunology].

Takeda K, Okumura K.

Hum Cell. 2001 Sep;14(3):159-63. Review. Japanese.

PMID:
11774735
19.
20.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis.

Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H, Okumura K.

J Exp Med. 2001 Mar 19;193(6):661-70.

Supplemental Content

Support Center